Open AccessRandomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy
Author(s) -
N. J. Shaheen,
J. Adler,
S. Dedrie,
D. Johnson,
P. Malfertheiner,
P. Miner,
A. Meulemans,
L. Poole,
J. Tack,
L. Thielemans,
S. Troy,
N. Vakil,
F. Zerbib,
M. Ruth
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ggef-9x94
Subject(s) - reflux , 5 ht4 receptor , gastro , medicine , agonist , disease , gastroenterology , receptor